The antithrombotic effect of human activated protein c on He-Ne laser-induced thrombosis in rat mesenteric microvessels
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
1989 • 1,209 citations
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
1989 • 1,199 citations
Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.
1982 • 434 citations
Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme
1982 • 385 citations
Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme
1982 • 308 citations
Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium
1985 • 305 citations
Natural anticoagulant mechanisms.
1984 • 251 citations
Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.
1989 • 241 citations
The Frequency of Type I Heterozygous Protein S and Protein C Deficiency in 141 Unrelated Young Patients with Venous Thrombosis
1988 • 227 citations
Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.
1990 • 227 citations
Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.
1993 • 222 citations
Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
1993 • 204 citations
Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
1991 • 152 citations
Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening.
1992 • 151 citations
Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis.
1990 • 122 citations
Heparin in the Prevention of Deep Vein Thrombosis after Myocardial Infarction
1972 • 110 citations
Hereditary deficiency of antithrombin III, protein C and protein S
1992 • 107 citations
Effect of Protein C and Activated Protein C on Coagulation and Fibrinolysis in Normal Human Subjects
1990 • 83 citations
Evans blue: An ideal energy-absorbing material to produce intravascular microinjury by HeNe gas laser
1975 • 77 citations
Prevention of Reocclusion by MCI-9038, a Thrombin Inhibitor, Following t-PA-lnduced Thrombolysis in a Canine Model of Femoral Arterial Thrombosis
1990 • 44 citations
The effect of thrombin inhibition in a rat arterial thrombosis model
1991 • 36 citations
Effect of Physical Training on Thrombotic Tendency in Rats: Decrease in Thrombotic Tendency Measured by the He-Ne Laser-Induced Thrombus Formation Method
1989 • 35 citations
Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries
1991 • 33 citations
The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels
1993 • 26 citations
Low doses of activated protein C delay arterial thrombosis in rats
1990 • 19 citations
Antithrombotic Effect of Argatroban on the Pial Vessels of the Rat: A Study with He-Ne Laser-Induced Thrombus Formation
1993 • 18 citations